These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 34866925)

  • 21. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mental health outcomes after SARS-CoV-2 vaccination in the United States: A national cross-sectional study.
    Chen S; Aruldass AR; Cardinal RN
    J Affect Disord; 2022 Feb; 298(Pt A):396-399. PubMed ID: 34774648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China.
    Zhang MX; Zhang TT; Shi GF; Cheng FM; Zheng YM; Tung TH; Chen HX
    Expert Rev Vaccines; 2021 Jul; 20(7):891-898. PubMed ID: 33929930
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study.
    Urakawa R; Isomura ET; Matsunaga K; Kubota K; Ike M
    BMC Infect Dis; 2022 Feb; 22(1):179. PubMed ID: 35197017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.
    Tamura T; Ninomiya K; Kubo T; Kuyama S; Tachibana S; Inoue K; Chikamori K; Kudo K; Ochi N; Harada D; Maeda Y; Kiura K
    Thorac Cancer; 2022 Feb; 13(3):453-459. PubMed ID: 34964270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey on the safety of the SARS-CoV-2 vaccine among a population with stroke risk in China.
    Wu G; Zhang M; Xie X; Zhu Y; Tang H; Zhu X; Liang Y; Chen T; Zhu K; Zhang D; Jiang S; Jiang Z; Ke S
    Front Med (Lausanne); 2022; 9():859682. PubMed ID: 36213663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.
    Lindgren AL; Austin AH; Welsh KM
    J Prim Care Community Health; 2021; 12():21501327211024431. PubMed ID: 34120504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Psoriatic Patient-Based Survey on the Understanding of the Use of Vaccines While on Biologics During the COVID-19 Pandemic [Formula: see text].
    Le H; Vender RB
    J Cutan Med Surg; 2021; 25(3):298-302. PubMed ID: 33504214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study.
    Dick A; Rosenbloom JI; Gutman-Ido E; Lessans N; Cahen-Peretz A; Chill HH
    BMC Pregnancy Childbirth; 2022 Feb; 22(1):166. PubMed ID: 35227233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.
    Ou MT; Boyarsky BJ; Motter JD; Greenberg RS; Teles AT; Ruddy JA; Krach MR; Jain VS; Werbel WA; Avery RK; Massie AB; Segev DL; Garonzik-Wang JM
    Transplantation; 2021 Oct; 105(10):2170-2174. PubMed ID: 33859151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining the frequency of serious adverse reactions of inactive SARS-COV-2 vaccine.
    Kaya F; Pirincci E
    Work; 2021; 69(3):735-739. PubMed ID: 34219684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.
    Castaldo M; Waliszewska-Prosół M; Koutsokera M; Robotti M; Straburzyński M; Apostolakopoulou L; Capizzi M; Çibuku O; Ambat FDF; Frattale I; Gadzhieva Z; Gallo E; Gryglas-Dworak A; Halili G; Jusupova A; Koperskaya Y; Leheste AR; Manzo ML; Marcinnò A; Marino A; Mikulenka P; Ong BE; Polat B; Popovic Z; Rivera-Mancilla E; Roceanu AM; Rollo E; Romozzi M; Ruscitto C; Scotto di Clemente F; Strauss S; Taranta V; Terhart M; Tychenko I; Vigneri S; Misiak B; Martelletti P; Raggi A;
    J Headache Pain; 2022 Mar; 23(1):41. PubMed ID: 35361131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.
    Jeong S; Lee N; Lee SK; Cho EJ; Hyun J; Park MJ; Song W; Jung EJ; Woo H; Seo YB; Park JJ; Kim HS
    J Clin Microbiol; 2021 Aug; 59(9):e0110521. PubMed ID: 34191577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
    Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG
    JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection.
    Bardenheier BH; Gravenstein S; Blackman C; Gutman R; Sarkar IN; Feifer RA; White EM; McConeghy K; Nanda A; Bosco E; Mor V
    J Am Med Dir Assoc; 2021 Nov; 22(11):2228-2232. PubMed ID: 34534492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.